IL6 and gastric ulcer: Upon the administration of drug interventions, there was a notable reduction in the levels of IL-1β, IL-6, and TNF-α in the gastric tissues of the positive group compared to the model group (p < 0.01), indicating that the treatment of gastric ulcers with the drug was associated with a decrease in the levels of these inflammatory cytokines.